60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio

Market Intelligence Analysis

AI-Powered
Why This Matters

60 Degrees Pharmaceuticals, Inc. has announced a 1:4 reverse stock split, set to take effect on January 20, 2026, which may impact the company's stock price and trading volume.

Market Impact

Market impact analysis based on neutral sentiment with 80% confidence.

Sentiment
Neutral
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that it will effect a one-for-four (1:4) reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on January 20, 2026, at 12:01 AM Eastern Time, before the opening of trading

Continue Reading
Full article on Unknown
Read Full Article
Original article published by Unknown on January 15, 2026.
Analysis and insights provided by AnalystMarkets AI.